For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or consult your doctor or pharmacist.
In the brain there are numerous different chemical compounds called neurotransmitters.
It is thought that when depression occurs, there may be a decreased amount of serotonin released from nerve cells in the brain.
SSRIs work by preventing serotonin from being reabsorbed back into the nerve cells in the brain.
Similarly, treatment with any MAOIs should not be started until at least one week after stopping treatment with sertraline.
There may be an increased risk of drowsiness or sedation if benzodiazepines or related medicines such as zolpidem and zaleplon are taken in combination with sertraline.
Lustral tablets contain the active ingredient sertraline hydrochloride, which is a type of antidepressant known as a selective serotonin reuptake inhibitor (SSRI).
Sertraline tablets are also available without a brand name, ie as the generic medicine.
These act as chemical messengers between the nerve cells.
Serotonin is one such neurotransmitter and has various functions that we know of.
When serotonin is released from nerve cells in the brain it acts to lighten mood.
When it is reabsorbed into the nerve cells, it no longer has an effect on mood.
This helps prolong the mood lightening effect of any released serotonin. Sertraline may also be used in the treatment of anxiety disorder, including obsessive compulsive disorder and post-traumatic stress disorder.